These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37271410)

  • 21. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography.
    Chen SW; Hoi KM; Mahfut FB; Yang Y; Zhang W
    Bioresour Bioprocess; 2022 Jul; 9(1):72. PubMed ID: 38647639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient production of bispecific antibody by FAST-Ig
    Koga H; Yamano T; Betancur J; Nagatomo S; Ikeda Y; Yamaguchi K; Nabuchi Y; Sato K; Teranishi-Ikawa Y; Sato M; Hirayama H; Hayasaka A; Torizawa T; Haraya K; Sampei Z; Shiraiwa H; Kitazawa T; Igawa T; Kuramochi T
    MAbs; 2023; 15(1):2222441. PubMed ID: 37339067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
    Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
    Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies.
    Wang B; Lin J; Hoag MR; Wright M; Ma M; Cai W; Gallolu Kankanamalage S; Liu Y
    Antib Ther; 2022 Jul; 5(3):216-225. PubMed ID: 36042698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity.
    Shatz W; Chung S; Li B; Marshall B; Tejada M; Phung W; Sandoval W; Kelley RF; Scheer JM
    MAbs; 2013; 5(6):872-81. PubMed ID: 23995614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving target cell specificity using a novel monovalent bispecific IgG design.
    Mazor Y; Oganesyan V; Yang C; Hansen A; Wang J; Liu H; Sachsenmeier K; Carlson M; Gadre DV; Borrok MJ; Yu XQ; Dall'Acqua W; Wu H; Chowdhury PS
    MAbs; 2015; 7(2):377-89. PubMed ID: 25621507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
    Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
    MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies.
    Giese G; Williams A; Rodriguez M; Persson J
    Biotechnol Prog; 2018 Mar; 34(2):397-404. PubMed ID: 29193902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling Mixed-Mode Size Exclusion Chromatography with Native Mass Spectrometry for Sensitive Detection and Quantitation of Homodimer Impurities in Bispecific IgG.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    Anal Chem; 2019 Sep; 91(17):11417-11424. PubMed ID: 31373790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectively removing the homodimer in bispecific antibodies by weak partitioning mode of anion exchange chromatography.
    Liang X; He Q; Qin G; Li G; Li Q; Tan H; Wang Z; Fan M; Xu D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123767. PubMed ID: 37270861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
    Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
    J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and quantification of chain-pairing variants or mispaired species of asymmetric monovalent bispecific IgG1 monoclonal antibody format using reverse-phase polyphenyl chromatography coupled electrospray ionization mass spectrometry.
    Poskute R; Sankaran PK; Sewell L; Lepore G; Shrubsall R; Dewis L; Watanabe Y; Wong V; Pascual Fernandez L; Mishra R; Holt A; Sou S; Harris C; Moreno Rodriguez C; Cankorur-Cetinkaya A; Smith J; Lonska N; Powell A; Cui T; Cheeks M; Lindo V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124085. PubMed ID: 38513430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS characterization and purity assessment of a prototype bispecific antibody.
    Woods RJ; Xie MH; Von Kreudenstein TS; Ng GY; Dixit SB
    MAbs; 2013; 5(5):711-22. PubMed ID: 23884083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds.
    Vaks L; Litvak-Greenfeld D; Dror S; Shefet-Carasso L; Matatov G; Nahary L; Shapira S; Hakim R; Alroy I; Benhar I
    Antibodies (Basel); 2018 Jul; 7(3):. PubMed ID: 31544879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG-like bispecific antibody platforms with built-in purification-facilitating elements.
    Li Y
    Protein Expr Purif; 2021 Dec; 188():105955. PubMed ID: 34416361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain.
    Schoonjans R; Willems A; Schoonooghe S; Leoen J; Grooten J; Mertens N
    Biomol Eng; 2001 Jun; 17(6):193-202. PubMed ID: 11337278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction.
    Elliott JM; Ultsch M; Lee J; Tong R; Takeda K; Spiess C; Eigenbrot C; Scheer JM
    J Mol Biol; 2014 May; 426(9):1947-57. PubMed ID: 24576605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
    Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
    MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of CrossMAb technology for the generation of bi- and multispecific antibodies.
    Klein C; Schaefer W; Regula JT
    MAbs; 2016; 8(6):1010-20. PubMed ID: 27285945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.